Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to learn more. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Matthew Johnson

Director, Government Relations & Advocacy

Matthew Johnson is the Director of Government Relations and Advocacy at NephCure, having joined in March 2024. He holds dual bachelor’s degrees in history and political science from Pennsylvania State University. Prior to his role at NephCure, he dedicated his career to impactful work at various non-profit organizations, accumulating over 7 years of experience in nonprofits. His extensive career in public service began, where he contributed to numerous legislative issues, including healthcare, showcasing more than 15 years of experience in government, policy, and advocacy.

Matthew calls Washington, DC home, where he lives with his wife Angie and their dog, Barkley. When he’s not deeply immersed in the intricacies of government affairs, you can catch him passionately cheering for Penn State football, jet-setting with his better half, and staying in the know about the latest in politics and pop culture.

Washington, D.C.

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.